Tuesday, Aug 4 2026 8:00AM - 9:30AM ET (GMT-4/UTC-4) at Loews in Regency A
| Innovation is a key driver of a firm's overall performance. Innovation has been represented as a multi-stage process starting with invention, proceeding through development, and ultimately commercialization, in which a firm finally captures some of the value created by its initial invention. The strategic management literature has primarily focused on the earliest stage of invention as there is a wealth of data available in the form of patents. As a result, scholars have paid less attention to the messier later stages of invention, namely development and commercialization. Yet, these stages of innovation are critical for a firm's ultimate success as it is through the ultimate development and commercialization of firms' new products and services that the return on firms' inventive efforts can be finally realized. In this presenter symposium, we focus on development and commercialization in the biopharmaceutical industry as there is a wealth of data available on these later stages of innovation in, for example, the form of clinical trial data. Through four presentations on the latest work in this domain and the subsequent discussant review, we hope to provide some insights into the factors that can shape firms' development and commercialization of their new product ideas. |
Presenter: John Eklund - University of Southern California
Presenter: Christine Choi - University of North Carolina at Chapel Hill
Presenter: Jennifer Kao - University of California Los Angeles
Presenter: Sungyong Chang - Cornell University
Discussant: Brian Silverman - University of Toronto
------------------------------
John Eklund
Associate Professor
University of Southern California
Los Angeles CA
------------------------------